Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Bartunek
Arthur W. Bartunek, New York, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20080248129 | COMPOUNDS AND METHODS FOR PROMOTING CELLULAR HEALTH AND TREATMENT OF CANCER - Systems and methods are provided herein that provide for promoting cellular health and treatment of cancer, and allied diseases such as diabetes and glaucoma. | 10-09-2008 |
| 20100239553 | METHODS FOR PROMOTING CELLULAR HEALTH AND TREATMENT OF CANCER - Systems and methods are provided herein that provide for promoting cellular health and treatment of cancer, and allied diseases such as diabetes and glaucoma. | 09-23-2010 |
Bernd Bartunek, Monhelm DE
| Patent application number | Description | Published |
|---|---|---|
| 20080213115 | High-Pressure Gas Compressor And Method Of Operating A High-Pressure Gas Compressor - A high-pressure gas compressor comprises a single-acting cam driven piston with a pressure compensation chamber disposed between the piston and the cam. A roller tappet assembly transmits reciprocating motion from the cam to the piston. A pressurized gas directed to the pressure compensation chamber offsets forces acting on the piston from the compression chamber gas pressure, thereby reducing Hertzian pressure between the tappet roller and the cam. Overall efficiency and durability can be improved by reducing friction between compressor components, for example by employing thin film coatings to reduce friction, pressurized oil lubrication systems and higher cylinder bore diameter to piston stroke ratios. The service life of gas seals and compression efficiency can be improved by thermal management strategies, including liquid-cooled compressor cylinder liners and intercoolers between compression stages. Employing a poppet-style intake valve and reducing parasitic volume in the compression chamber can improve compressor volumetric efficiency. | 09-04-2008 |
Josh Bartunek, Chanhassen, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20100303261 | User Interface For Network Audio Mixers - Briefly, in accordance with one or more embodiments, a first mixer connects to a network and if a second mixer is detected on the network, the first mixer obtains an identifier for the second mixer, adds one or more audio signals from the second mixer to a mix of the first mixer, and stores a mix setting for the second mixer on the first mixer. If the second mixer is subsequently connected to the first mixer, the first mixer obtains the identifier for the second mixer, recalls the stored mix setting for the second mixer based at least in part on the identifier, and adds one or more audio signals from the second mixer to a present mix of the first mixer based at least in part on the recalled mix setting. | 12-02-2010 |
Jozef Bartunek, Gent BE
| Patent application number | Description | Published |
|---|---|---|
| 20110158996 | VON WILLEBRAND FACTOR SPECIFIC BINDERS AND METHODS OF USE THEREFOR - The invention provides new uses for specific binders to the Al domain of the von Willebrand Factor (vWF), in particular the use in patients with stable angina undergoing elective percutaneous coronary intervention. Furthermore, dosing schedules and use of suitable assays such as RIPA and RICO in the particular disease settings are provided. | 06-30-2011 |
Petr Bartunek, Praha 1 CZ
| Patent application number | Description | Published |
|---|---|---|
| 20110118225 | Ligands of Estrogen Receptors alpha and beta, Method of Their Preparation, and Pharmaceuticals Comprising Them - The invention relates to novel ligands of the estrogen receptors α and β of general formula II, which are useful as an active substance of pharmaceuticals, for example pharmaceutical compositions useful for hormone replacement therapy, as well as for the treatment of tumors and inflammatory diseases. The invention also relates to a novel preparation method of these ligands comprising cyclotrimerization of ethynylestradiol with the appropriate diyne in an organic solvent. Further, the invention relates to pharmaceuticals comprising the novel compounds according to the invention. | 05-19-2011 |